RS
Therapeutic Areas
Oculis Pipeline
| Drug | Indication | Phase |
|---|---|---|
| OCS-01 | Diabetic Macular Edema (DME) | Phase 3 |
| Licaminlimab (OCS-02) | Dry Eye Disease (DED) | Phase 2/3 |
| Privosegtor (OCS-05) | Optic Neuritis | Phase 2 |
| Drug | Indication | Phase |
|---|---|---|
| OCS-01 | Diabetic Macular Edema (DME) | Phase 3 |
| Licaminlimab (OCS-02) | Dry Eye Disease (DED) | Phase 2/3 |
| Privosegtor (OCS-05) | Optic Neuritis | Phase 2 |